FDA Accepts Priority Review Application for Dupilumab for Pediatric Eosinophilic Esophagitis

Press/Media

Period	26 Sep 2023

Media coverage

Title	FDA Accepts Priority Review Application for Dupilumab for Pediatric Eosinophilic Esophagitis
Media name/outlet	HCPLive
Country/Territory	United States
Date	26/09/23
URL	https://www.hcplive.com/view/fda-accepts-priority-review-application-for-dupilumab-for-pediatric-eosinophilic-esophagitis
Persons	Mirna Chehade